Related Experiment Video
Updated: Feb 18, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Mechanism of tandem duplication formation in BRCA1-mutant cells
Nicholas A Willis1, Richard L Frock2, Francesca Menghi3
1Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
Small, approximately 10-kilobase microhomology-mediated tandem duplications are abundant in the genomes of BRCA1-linked but not BRCA2-linked breast cancer. Here we define the mechanism underlying this rearrangement signature. We show that, in primary mammalian cells, BRCA1, but not BRCA2, suppresses the formation of tandem duplications at a site-specific chromosomal replication fork barrier imposed by the binding of Tus proteins to an array of Ter sites. BRCA1 has no equivalent role at chromosomal double-stranded DNA breaks, indicating that tandem duplications form specifically at stalled forks. Tandem duplications in BRCA1 mutant cells arise by a replication restart-bypass mechanism terminated by end joining or by microhomology-mediated template switching, the latter forming complex tandem duplication breakpoints. Solitary DNA ends form directly at Tus-Ter, implicating misrepair of these lesions in tandem duplication formation. Furthermore, BRCA1 inactivation is strongly associated with ~10 kilobase tandem duplications in ovarian cancer. This tandem duplicator phenotype may be a general signature of BRCA1-deficient cancer.
Insights
BRCA1 deficiency drives the formation of ~10 kilobase tandem duplications by preventing replication fork restart. This tandem duplicator phenotype is a signature of BRCA1-deficient cancers, including breast and ovarian cancers.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Cancer Research
Background:
- Microhomology-mediated tandem duplications (MDTs) are prevalent in BRCA1-linked breast cancer.
- The precise mechanism driving this genomic instability in BRCA1-deficient cancers remains unclear.
- BRCA1 and BRCA2 proteins play critical roles in DNA repair and genome maintenance.
Purpose of the Study:
- To elucidate the mechanism underlying the formation of ~10 kilobase tandem duplications associated with BRCA1 deficiency.
- To investigate the role of BRCA1 and BRCA2 in suppressing tandem duplications at replication fork barriers.
- To determine if this tandem duplicator phenotype is a general signature of BRCA1-deficient cancers.
Main Methods:
- Utilized primary mammalian cells to study tandem duplication formation at a site-specific replication fork barrier (Tus-Ter system).
- Compared the roles of BRCA1 and BRCA2 in suppressing tandem duplications.
- Investigated the mechanisms of replication restart, bypass, and DNA end joining in BRCA1-mutant cells.
- Analyzed the association of ~10 kilobase tandem duplications with BRCA1 inactivation in ovarian cancer.
Main Results:
- BRCA1, but not BRCA2, suppresses tandem duplications at stalled replication forks created by Tus-Ter binding.
- Tandem duplications in BRCA1-mutant cells arise from replication restart-bypass mechanisms, involving end joining or microhomology-mediated template switching.
- Solitary DNA ends at Tus-Ter sites suggest misrepair contributes to tandem duplication formation.
- BRCA1 inactivation is strongly linked to ~10 kilobase tandem duplications in ovarian cancer.
Conclusions:
- BRCA1 deficiency leads to a tandem duplicator phenotype specifically at stalled replication forks.
- The mechanism involves impaired replication restart and subsequent DNA repair events.
- This tandem duplicator phenotype is a potential pan-cancer biomarker for BRCA1 deficiency, extending beyond breast to ovarian cancer.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Homologous Recombination
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

